Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Cell & Gene Therapy
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Subscribe
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Cell & Gene Therapy
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Karuna Therapeutics
Biotech
Schizophrenia-minded Syremis takes off with $165M series A
Founded by a team of neuropsychiatric-focused Teva alums and the force behind Cobenfy maker Karuna, Syremis touts a M1/M4 agonist and other prospects.
Zoey Becker
Dec 18, 2025 12:59pm
Seaport loads $225M for Karuna vets' voyage to milestones
Oct 21, 2024 8:05am
Top 10 smartest deals in biopharma
Jun 24, 2024 6:00am
Xaira, Anthos, CureVac & more—Chutes & Ladders
Apr 26, 2024 8:30am
BIO, Seaport, Orna and more—Chutes & Ladders
Apr 12, 2024 8:30am
Karuna's captains set sail in new neuropsychiatric biotech
Apr 9, 2024 8:25am
